COSMOS

Astera Labs Announces Financial Results for the First Quarter of Fiscal Year 2024

Retrieved on: 
tisdag, maj 7, 2024
Software, Networks, Internet, Hardware, Artificial Intelligence, Data Management, Technology, Semiconductor, Cloud, CPU, COSMOS, AMD, ALAB, Pandemic, CXL, AI, PCI Express, Health, Security (finance), Epidemic, Webcast, Growth, Information technology, Environment, IPO, Tax, Intel, EPS, Terrorism, NVIDIA, GPU, Bank statement, Graphics processing unit, GAAP, Labs, Interest, Video game

Astera Labs (Nasdaq: ALAB), a global leader in semiconductor-based connectivity solutions for cloud and AI infrastructure, today announced preliminary financial results for the first quarter of fiscal 2024, ended March 31, 2024.

Key Points: 
  • Astera Labs (Nasdaq: ALAB), a global leader in semiconductor-based connectivity solutions for cloud and AI infrastructure, today announced preliminary financial results for the first quarter of fiscal 2024, ended March 31, 2024.
  • “Astera Labs started the year strong, achieving record revenue in the first quarter, driven by the accelerating deployment of AI infrastructure,” said Jitendra Mohan, Astera Labs’ Chief Executive Officer.
  • Net proceeds to Astera Labs from the offering were $672.2 million after deducting underwriting discounts and commissions.
  • We also estimate the following:
    Astera Labs will host a conference call to review its financial results for the first quarter of fiscal 2024 and to discuss our financial outlook today at 1:30 p.m. Pacific Time.

AERWINS Technologies Announces Additional Staff Determination

Retrieved on: 
tisdag, april 23, 2024
COSMOS, Security (finance), Research, Tokyo District Court, Form, Intelligence, Centralisation, Panel, Form 10-K, Cryptocurrency

LOS ANGELES, CA, April 23, 2024 (GLOBE NEWSWIRE) -- AERWINS Technologies Inc. (Nasdaq: AWIN) (“AERWINS” or “the Company”) today announced that on April 17, 2024, the Company received an Additional Staff Delisting Determination (the “Additional Staff Determination”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”).

Key Points: 
  • LOS ANGELES, CA, April 23, 2024 (GLOBE NEWSWIRE) -- AERWINS Technologies Inc. (Nasdaq: AWIN) (“AERWINS” or “the Company”) today announced that on April 17, 2024, the Company received an Additional Staff Delisting Determination (the “Additional Staff Determination”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”).
  • The Additional Staff Determination noted that the Company is now delinquent in filing its Form 10-K for the period ended December 31, 2023 (the “Form 10-K”), which additional delinquency may serve as a separate basis for the delisting of the Company’s securities from Nasdaq.
  • The Additional Staff Determination notified the Company that the Nasdaq Hearings Panel (the “Panel”) will consider this matter in their decision regarding the Company’s continued listing on The Nasdaq Capital Market and that it should present its views with respect to this additional deficiency to the Panel in writing no later than April 24, 2024.
  • Additional information about the Additional Determination can be found in the Company’s Form 8-K filed with the Securities and Exchange Commission on April 23, 2024.

UPCX Wallet Set to Launch Public Testnet, Aiming to Reshape the Crypto Payment Experience

Retrieved on: 
fredag, april 5, 2024
Communication, DEX, Attention, POS, Ecosystem, Blockchain, NFA, UIA, Finance Secretary (India), Life, NFC, MPA, Denial-of-service attack, System, API, COSMOS, Mobile payment, Privacy, IDS, Cryptocurrency

The UPCX Wallet is currently in a closed network testing phase and is not yet available to the general public.

Key Points: 
  • The UPCX Wallet is currently in a closed network testing phase and is not yet available to the general public.
  • Super APP Ecosystem: In the future, the UPCX Wallet will become the core payment gateway within the UPCX Super APP ecosystem.
  • As the public testnet progresses and the forthcoming user experience arrives, UPCX Wallet is expected to establish a foothold in the crypto payment sector and attract widespread attention.
  • UPCX is a blockchain-based open-source payment platform that aims to provide secure, transparent, and compliant financial services to global users.

PAWR Program Announces Dramatic Expansion of AERPAW Drone Testbed with Phase Two Launch

Retrieved on: 
måndag, mars 18, 2024
Hardware, Other Defense, Contracts, Government Technology, Technology, Defense, 5G, Drones, Science, Telecommunications, Software, Networks, Other Science, Mobile, Wireless, Research, Aircraft, Project management office, Interdisciplinarity, UAV, POWDER, Classification, Commercial, Unmanned aerial vehicle, Radio, PAWR, North Carolina State University, Federal, Atmosphere, COSMOS, Ericsson, Multimedia, Platform, ARA, Computer, Federal Communications Commission, Mobile phone

AERPAW has also been designated as an Open Test and Integration Center (OTIC) by the O-RAN ALLIANCE.

Key Points: 
  • AERPAW has also been designated as an Open Test and Integration Center (OTIC) by the O-RAN ALLIANCE.
  • Software defined radios (SDRs) enable research with open source software stacks for studying and optimizing the performance of radio signals.
  • Unique to AERPAW, the wireless testbed brings with it several assets specific to testing drone-based networks.
  • “The expansion of AERPAW opens up vast new avenues of research,” said Ismail Guvenc, AERPAW Principal Investigator, and engineering professor at NC State University.

PAWR Announces 5G Open RAN Testing with Mavenir at POWDER Testbed

Retrieved on: 
torsdag, mars 14, 2024
Technology, Mobile, Wireless, 5G, Networks, Internet, Hardware, Carriers and Services, Project management office, FCC, The Open Championship, Agility, Mavenir, Exercise, MMW, POWDER, University, Software, City, MDE, PAWR, Research Triangle, Federal, COSMOS, Multimedia, Platform, ARA, Triangle, Federal Communications Commission, Open, Mobile phone

The Platforms for Advanced Wireless Research (PAWR) Project Office announces a collaboration between PAWR platform POWDER and industry innovator Mavenir to test a first-of-its-kind O-RAN 5G SA network deployment with millimeter Wave (mmWave) spectrum.

Key Points: 
  • The Platforms for Advanced Wireless Research (PAWR) Project Office announces a collaboration between PAWR platform POWDER and industry innovator Mavenir to test a first-of-its-kind O-RAN 5G SA network deployment with millimeter Wave (mmWave) spectrum.
  • The solution is powered by Mavenir’s open radio unit (O-RU), open distributed unit (O-DU), open centralized unit (O-CU), and 5G core.
  • In the summer of 2023, POWDER was designated as an Open Testing and Integration Center (OTIC) by the O-RAN ALLIANCE.
  • "The POWDER team is excited to collaborate with Mavenir to test their O-RAN 5G mmW SA solution in an over-the-air setup on POWDER.

Astera Labs Expands Widely Deployed, Field-Tested Retimer Portfolio with Industry’s Lowest Power PCIe 6.x/CXL 3.x Solution

Retrieved on: 
tisdag, mars 12, 2024
Software, Networks, Hardware, Artificial Intelligence, Data Management, Technology, Apps, Applications, Semiconductor, Cloud, Corporation, Intel, Synthetic media, GPU, HPC, Gold, AI, CXL, PCI Express, Engineering, Intelligence, Silicon, Senior, Generative, Graphics processing unit, NIC, Data center, ARM Neoverse, Ecosystem, Aries, COSMOS, AMD, Transfer (computing), Central processing unit, CPU, Rack, Video game

New Aries 6 Retimers build upon the company’s widely deployed PCIe 5.0 Retimer portfolio and expands the Intelligent Connectivity Platform that is shipping to all major hyperscalers and AI platform providers.

Key Points: 
  • New Aries 6 Retimers build upon the company’s widely deployed PCIe 5.0 Retimer portfolio and expands the Intelligent Connectivity Platform that is shipping to all major hyperscalers and AI platform providers.
  • As the first offering in Astera Labs’ PCIe 6.x portfolio, Aries 6 sets the stage for a smart PCIe 6.x connectivity backbone that is robust, scalable, and customizable.
  • The Aries Smart DSP Retimer portfolio is rigorously tested in Astera Labs’ Cloud-Scale Interop Lab and in customer platforms to ensure seamless plug-and-play interoperability with leading PCIe ecosystem silicon providers.
  • Schedule to meet with Astera Labs experts and learn how its solutions enable critical connectivity for AI and cloud infrastructure.

VAV Enters LatAM with High-Purity Lipids, Eyes 40% Share in Five Years

Retrieved on: 
torsdag, mars 7, 2024
Cosmetics, Retail, Health, Research, Science, Pharmaceutical, Biotechnology, ISO, COSMOS, USD, Food safety, Marketing, United States Pharmacopeia, Lecithin, Occupational safety and health, OSHA, Vaccine, API, Anesthesia, VAV, Phospholipid, Liposome, USP, All, Kedia

VAV Lipids is headquartered in Mumbai, India and is among the world’s leading manufacturers of phospholipids and lecithins.

Key Points: 
  • VAV Lipids is headquartered in Mumbai, India and is among the world’s leading manufacturers of phospholipids and lecithins.
  • The biopharmaceutical company manufactures plant phospholipids (LECIVA), egg phospholipids (LIPOVA), synthetic phospholipids and neutral lipids, APIs and specialty proteins.
  • VAV Lipids will introduce its entire range of products through the company’s distribution network in Latin America.
  • Arun Kedia, Managing Director of VAV Lipids, said, “Our expansion into Latin America will boost our global presence significantly.

Woman Founded: Natracare's innovative Moist Tissue is First in its Category to Attain COSMOS Natural Certification

Retrieved on: 
tisdag, mars 5, 2024
Chlorine, Health, COSMOS, Family, Soil, Certification, Soil Association, Tissue paper

CHICAGO, March 5, 2024 /PRNewswire/ -- Natracare, a trailblazer in sustainable feminine hygiene products, is pleased to announce that its Safe to Flush Moist Tissue has been awarded COSMOS NATURAL certification by the Soil Association. This significant achievement exemplifies Natracare's dedication to providing environmentally conscious and responsibly sourced personal care items. To qualify for COSMOS NATURAL certification, a product's entire supply chain is considered. All ingredients must meet green chemistry principles, packaging and cleaning materials are checked and all facilities are inspected.

Key Points: 
  • CHICAGO, March 5, 2024 /PRNewswire/ -- Natracare , a trailblazer in sustainable feminine hygiene products, is pleased to announce that its Safe to Flush Moist Tissue has been awarded COSMOS NATURAL certification by the Soil Association.
  • To qualify for COSMOS NATURAL certification, a product's entire supply chain is considered.
  • COSMOS-standard General Manager Laurent Milet remarked, "Natracare proudly introduces the first moist tissues in the US to achieve COSMOS NATURAL certification, reinforcing our commitment to providing eco-friendly and ethically sourced products.
  • As part of the COSMOS family, Natracare continues to set a new standard for natural and sustainable personal care."

Astera Labs Unveils PCI Express Cable Solutions that Accelerate Cloud and AI Infrastructure Deployments at Scale

Retrieved on: 
tisdag, januari 30, 2024
Data Management, Semiconductor, Technology, Networks, Artificial Intelligence, Internet, Hardware, Reliability, ICS, Graphics processing unit, Memory, Knowledge, Wire, GPU, Aries, AI, AEC, SCMS, Total cost of ownership, RAS, Central processing unit, Electricity, PCI Express, Cable gland, CXL, AOC, Santa Clara Convention Center, SCM, COSMOS, Total cost, TCO, Video game

Astera Labs, the global leader in semiconductor-based connectivity solutions for cloud and AI infrastructure, today announced the sampling of its Aries PCIe® and CXL® Smart Cable Modules™ (SCM) which provide robust and long reach copper cabling connectivity for GPUs, CPUs, and memory in disaggregated cloud and AI infrastructure.

Key Points: 
  • Astera Labs, the global leader in semiconductor-based connectivity solutions for cloud and AI infrastructure, today announced the sampling of its Aries PCIe® and CXL® Smart Cable Modules™ (SCM) which provide robust and long reach copper cabling connectivity for GPUs, CPUs, and memory in disaggregated cloud and AI infrastructure.
  • Thad Omura, Chief Business Officer, Astera Labs, said, “Active PCIe/CXL cables have emerged as a critical connectivity solution for multi-rack GPU clusters and low-latency memory fabrics for AI infrastructure that has physically out-grown a single rack enclosure.
  • Astera Labs’ full portfolio of Aries SCMs will also include an Active Optical Cable (AOC) solution in the future.
  • Schedule to meet with Astera Labs experts and learn how its PCIe, Ethernet, and CXL solutions are enabling critical connectivity for cloud and AI infrastructure.

Guardant Health to present data at ASCO GI supporting use of liquid biopsy to predict colon cancer recurrence

Retrieved on: 
onsdag, januari 17, 2024
Technology, FDA, Health, Professional Services, Artificial Intelligence, Oncology, Public Relations, Investor Relations, Software, General Health, Data Analytics, Communications, Health Technology, Data Management, Clinical Trials, Probability, Patient, MRD, Research, Neoplasm, Biomarker, DNA, ASCO, COBRA, Recurrence, Blood, Disease, Interim, Circulating tumor DNA, CRC, Colorectal cancer, COSMOS

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, will present interim data from the COSMOS study supporting the use of Guardant Reveal to predict disease recurrence in patients with early-stage colon cancer at the ASCO 2024 Gastrointestinal Cancers Symposium, January 18-20 in San Francisco.

Key Points: 
  • Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, will present interim data from the COSMOS study supporting the use of Guardant Reveal to predict disease recurrence in patients with early-stage colon cancer at the ASCO 2024 Gastrointestinal Cancers Symposium, January 18-20 in San Francisco.
  • Guardant Reveal analyzes comprehensive molecular signals in the blood to detect and quantify minimal residual disease (MRD).
  • The COSMOS study evaluated the use of the newest version of the test, built on the Guardant Infinity™ smart liquid biopsy platform, to identify MRD and predict disease recurrence in 130 patients with early-stage (II and III) colon cancer.
  • “Studies have established the presence of residual disease after surgery is associated with a higher probability of recurrence in early-stage colon cancer,” said Craig Eagle, M.D., Guardant Health chief medical officer.